RANI
Price
$0.53
Change
+$0.02 (+3.92%)
Updated
Jul 2 closing price
Capitalization
17.85M
35 days until earnings call
VNDA
Price
$4.89
Change
+$0.21 (+4.49%)
Updated
Jul 2 closing price
Capitalization
288.19M
21 days until earnings call
Interact to see
Advertisement

RANI vs VNDA

Header iconRANI vs VNDA Comparison
Open Charts RANI vs VNDABanner chart's image
Rani Therapeutics Holdings
Price$0.53
Change+$0.02 (+3.92%)
Volume$128.48K
Capitalization17.85M
Vanda Pharmaceuticals
Price$4.89
Change+$0.21 (+4.49%)
Volume$339.32K
Capitalization288.19M
RANI vs VNDA Comparison Chart in %
Loading...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RANI vs. VNDA commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RANI is a StrongBuy and VNDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (RANI: $0.53 vs. VNDA: $4.89)
Brand notoriety: RANI and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RANI: 24% vs. VNDA: 74%
Market capitalization -- RANI: $17.85M vs. VNDA: $288.19M
RANI [@Biotechnology] is valued at $17.85M. VNDA’s [@Biotechnology] market capitalization is $288.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RANI’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • RANI’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RANI’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 6 bullish TA indicator(s).

  • RANI’s TA Score: 4 bullish, 2 bearish.
  • VNDA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than RANI.

Price Growth

RANI (@Biotechnology) experienced а +5.10% price change this week, while VNDA (@Biotechnology) price change was +6.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

RANI is expected to report earnings on Aug 07, 2025.

VNDA is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($288M) has a higher market cap than RANI($17.9M). VNDA YTD gains are higher at: 2.088 vs. RANI (-61.182). RANI has higher annual earnings (EBITDA): -48.83M vs. VNDA (-64.56M). VNDA has more cash in the bank: 341M vs. RANI (15.9M). VNDA has less debt than RANI: VNDA (11.7M) vs RANI (25.7M). VNDA has higher revenues than RANI: VNDA (201M) vs RANI (1.2M).
RANIVNDARANI / VNDA
Capitalization17.9M288M6%
EBITDA-48.83M-64.56M76%
Gain YTD-61.1822.088-2,931%
P/E RatioN/A126.00-
Revenue1.2M201M1%
Total Cash15.9M341M5%
Total Debt25.7M11.7M220%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RANIVNDA
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBR31.361.78
+6.02%
Nabors Industries Ltd
RNA29.370.91
+3.20%
Avidity Biosciences
ESOA10.240.30
+3.02%
Energy Services of America Corp
BRFH3.35N/A
N/A
Barfresh Food Group
NWG13.01-0.88
-6.34%
NatWest Group plc

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+3.56%
XENE - RANI
36%
Loosely correlated
+6.61%
ADVM - RANI
32%
Poorly correlated
-0.88%
DRUG - RANI
31%
Poorly correlated
+5.38%
UBX - RANI
31%
Poorly correlated
-13.14%
VNDA - RANI
30%
Poorly correlated
+4.49%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AVIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+4.49%
AVIR - VNDA
43%
Loosely correlated
+0.69%
EYPT - VNDA
42%
Loosely correlated
+1.15%
CLDX - VNDA
41%
Loosely correlated
+8.65%
PGEN - VNDA
40%
Loosely correlated
+11.38%
IVF - VNDA
40%
Loosely correlated
+1.40%
More